Company: LIMN
Filing Date: 2025-06-24
Form Type: S-1
Source: 0001410578-25-001432
Chunk: 188

Company: Liminatus Pharma, Inc.
Filing Date: 2025-06-24
Form: S-1
Chunk 188
---
arrants of each Selling Securityholder, the number of shares of Common Stock and number of Warrants that may be sold by each Selling Securityholders under this prospectus and that each Selling Securityholders will beneficially own after this offering. We have based percentage ownership on 26,014,633 shares of Common Stock outstanding as of the date of this prospectus. Because each Selling Securityholder may dispose of all, none or some portion of their securities, no estimate can be given as to the number of securities that will be beneficially owned by a Selling Securityholder upon termination of this offering. For purposes of the table below, however, we have assumed that after termination of this offering none of the securities covered by this prospectus will be

118

beneficially owned by the Selling Securityholder and further assumed that the Selling Securityholder will not acquire beneficial ownership of any additional securities during the offering. In addition, the Selling Securityholder may have sold, transferred or otherwise disposed of, or may sell, transfer or otherwise dispose of, at any time and from time to time, our securities in transactions exempt from the registration requirements of the Securities Act after the date on which the information in the table is presented. Unless otherwise indicated below, the address of each Selling Securityholder listed in the tables below is c/o Liminatus Pharma, Inc., 6 Centerpointe Drive #625, La Palma, California 90623.

| ​                                | ​ |            ​ | ​ |          ​ | ​ | ​            | ​ | ​        |
| ​                                | ​ |       Number |   |          ​ |   | Number       |   | ​        |
| ​                                | ​ | Beneficially | ​ |     Number | ​ | Beneficially | ​ | Percent  |
| ​                                | ​ |        Owned | ​ | Registered | ​ | Owned        | ​ | Owned    |
| ​                                | ​ |     Prior to | ​ |   for Sale | ​ | After        | ​ | After    |
| Name                             |   |     Offering |   |     Hereby |   | Offering     |   | Offering |
| Valetudo Therapeutics LLC(1)     | ​ |    6,169,406 | ​ |  6,169,406 | ​ | —            | ​ | —        |
| KH Feelux Co., Ltd(2)            | ​ |    4,000,000 | ​ |  4,000,000 | ​ | —